Clinical Trial: Emulation of the Study of Tirzepatide Compared with Dulaglutide on Major Cardiovascular Events in Participants with Type 2 Diabetes (SURPASS-CVOT)

U.S., Jan. 18 -- ClinicalTrials.gov registry received information related to the study (NCT06779929) titled 'Emulation of the Study of Tirzepatide Compared with Dulaglutide on Major Cardiovascular Events in Participants with Type 2 Diabetes (SURPASS-CVOT)' on Jan. 10.

Brief Summary: This cohort study was initiated to emulate the design of the SURPASS-CVOT trial using observational analogues of the trial design components in a study based on insurance claims data.

Study Start Date: Nov. 01, 2024

Study Type: OBSERVATIONAL

Condition: Type 2 Diabetes

Intervention: DRUG: Tirzepatide

Tirzepatide

DRUG: Dulaglutide

Dulaglutide

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Brigham and Women's Hospital

Information provided by (Respo...